Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report)’s share price was up 1.2% during mid-day trading on Monday. The stock traded as high as $35.94 and last traded at $35.83. 9,000 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 52,622 shares. The stock had previously closed at $35.39.
Innovator IBD 50 ETF Stock Performance
The firm’s 50-day moving average is $36.21 and its 200 day moving average is $37.92. The firm has a market capitalization of $69.54 million, a price-to-earnings ratio of 30.34 and a beta of 1.48.
Institutional Trading of Innovator IBD 50 ETF
Several institutional investors have recently modified their holdings of FFTY. KFG Wealth Management LLC acquired a new position in shares of Innovator IBD 50 ETF in the second quarter worth approximately $201,000. Trail Ridge Investment Advisors LLC bought a new stake in shares of Innovator IBD 50 ETF in the 2nd quarter valued at $210,000. Royal Bank of Canada lifted its position in shares of Innovator IBD 50 ETF by 3,222.5% during the 1st quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after acquiring an additional 17,724 shares during the period. Guardian Wealth Advisors LLC NC acquired a new position in shares of Innovator IBD 50 ETF during the 2nd quarter valued at $507,000. Finally, WorthPointe LLC boosted its stake in Innovator IBD 50 ETF by 18.3% during the second quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock worth $1,295,000 after acquiring an additional 3,771 shares in the last quarter.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Read More
- Five stocks we like better than Innovator IBD 50 ETF
- RPM International’s Dividend King Status Just Got Stronger
- The AI Boom’s Next Big Winners May Wear Hard Hats
- Rivian Escapes the EV Graveyard—But Can It Stay Alive?
- Allient’s Data Center and Defense Momentum Is Raising the Stakes
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
